Factors Influencing Driving following DBS Surgery in Parkinson's Disease: A Single UK Centre Experience and Review of the Literature

• Published in: Journal of clinical medicine Vol. 12; no. 1; p. 166
• Main Authors: Furlanetti, Luciano, Baig Mirza, Asfand, Raslan, Ahmed, Velicu, Maria Alexandra, Burford, Charlotte, Akhbari, Melika, German, Elaine, Saha, Romi, Samuel, Michael, Ashkan, Keyoumars
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 25.12.2022; MDPI
• Subjects: Clinical medicine; Deep brain stimulation; Dyskinesia; Executive function; Memory; Multidisciplinary teams; Neuropsychology; Parkinson's disease; Patients; Quality of life; Sentence completion tests; Surgery; United Kingdom > UK; United States > US; driving; neurodegenerative diseases; ageing; rehabilitation; subthalamic nucleus; Parkinson’s disease; deep brain stimulation
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm12010166

Parkinson's disease (PD) is a complex neurodegenerative disorder, leading to impairment of various neurological faculties, including motor, planning, cognitivity, and executive functions. Motor- and non-motor symptoms of the disease may intensify a patient's restrictions to performing usual tasks of daily living, including driving. Deep Brain Stimulation (DBS) associated with optimized clinical treatment has been shown to improve quality of life, motor, and non-motor symptoms in PD. In most countries, there are no specific guidelines concerning minimum safety requirements and the timing of return to driving following DBS, leaving to the medical staff of individual DBS centres the responsibility to draw recommendations individually regarding patients' ability to drive after surgery. The aim of this study was to evaluate factors that might influence the ability to drive following DBS in the management of PD. A total of 125 patients were included. Clinical, epidemiological, neuropsychological, and surgical factors were evaluated. The mean follow-up time was 129.9 months. DBS improved motor and non-motor symptoms of PD. However, in general, patients were 2.8-fold less likely to drive in the postoperative period than prior to surgery. Among the PD characteristics, patients with the akinetic subtype presented a higher risk to lose their driving licence postoperatively. Furthermore, the presence of an abnormal postoperative neuropsychological evaluation was also associated with driving restriction following surgery. Our data indicate that restriction to drive following surgery seems to be multifactorial rather than a direct consequence of DBS itself. Our study sheds light on the urgent need for a standardised multidisciplinary postoperative evaluation to assess patients' ability to drive following DBS.